Mike Ouimette - Dec 22, 2022 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role: General Counsel & Corp. Sec'y
Signature: /s/ Mike Ouimette
Stock symbol: PLRX
Transactions as of: Dec 22, 2022
Transactions value $: -$56,731
Form type: 4
Date filed: 12/23/2022, 04:34 PM
Previous filing: Dec 21, 2022
Next filing: Jan 25, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PLRX	Common Stock	Sale	-$56.7K	-2.93K	-32.99%	$19.38	5.95K	Dec 22, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 4, 2022.
F2	The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.86 to $19.57, inclusive. The Reporting Person undertakes to provide to Pliant Therapeutics, Inc., any security holder of Pliant Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Content

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 4, 2022.

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.86 to $19.57, inclusive. The Reporting Person undertakes to provide to Pliant Therapeutics, Inc., any security holder of Pliant Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.